A SYSTEMIC REVIEW ON CLINICAL EFFICACY AND SAFETY OF GABAPENTIN

Volume 20 No 6 (2022)

PRATHYUSHA RANI.T , AKILADEVI D

DOI: 10.14704/nq.2022.20.6.NQ22837

Abstract

Therapeutic Drug Monitoring (TDM) of antiepileptic drugs (AEDs) isn't regularly performed for all epilepsy patients, although this can guide for an individualized dosage regimen to achieve greater efficacy and safety. Gabapentin was initially affirmed in 1994 in the United States for the treatment of epilepsy with a proper pharmacokinetic (PK) profile

Keywords

Therapeutic drug monitoring, Epilepsy, Gabapentin, Pharmacokinetic

Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.